Wee1 kinase differentially regulates maize CDKA2;1a and CDKB1;1

Mingyar N López-Hernández1, Estefany D Guerrero-Molina1, Ulises Martínez-Ortega2

  • 1Facultad de Química, Departamento de Bioquímica, Universidad Nacional Autónoma de México, México.

The FEBS Journal
|May 30, 2026
PubMed

Insights

Maize Wee1 kinase modulates plant cell cycle progression by affecting cyclin-dependent kinases (CDKs). It inhibits CDK activity and alters substrate recognition, revealing complex regulatory roles beyond simple inhibition.

Area of Science:

  • Plant Molecular Biology
  • Cell Cycle Regulation
  • Enzymology

Background:

  • Cyclin-dependent kinase/cyclin (CDK/Cyc) complexes are crucial for eukaryotic cell cycle control.
  • Wee1 kinase regulates CDK activity through phosphorylation, a mechanism vital for mitosis in vertebrates.
  • Wee1 function in plants, particularly in maize, remains less understood compared to other model organisms.

Purpose of the Study:

  • To investigate the conserved function of Wee1 kinase in maize.
  • To determine the in vitro effects of maize Wee1 on maize CDKA2;1a and CDKB1;1.
  • To elucidate the mechanisms by which Wee1 modulates CDK activity and substrate specificity in plants.

Main Methods:

  • In vitro kinase assays using purified maize Wee1, CDKA2;1a, and CDKB1;1.
  • Phosphorylation analysis of CDKs by Wee1.
  • Assessment of CDK/cyclin substrate phosphorylation and autophosphorylation.
  • Analysis of Wee1 phosphorylation by CDKs.

Main Results:

  • Maize Wee1 phosphorylated CDKB1;1.
  • Wee1 inhibited the kinase activity of both CDKA2;1a and CDKB1;1, independent of its own kinase activity, in a substrate-dependent manner.
  • Wee1 phosphorylation of CDKB1;1 inhibited its activation via autophosphorylation and altered substrate phosphorylation.
  • Both CDKA2;1a and CDKB1;1 differentially phosphorylated Wee1.

Conclusions:

  • Maize Wee1 modulates maize CDK activity through multiple mechanisms, including direct inhibition and alteration of substrate recognition.
  • These findings differ from previous reports and suggest a more complex regulatory role for plant Wee1.
  • Wee1's interaction with CDKs in maize influences cell cycle progression through intricate regulatory pathways.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...